Delivery Order SPE2DB22D1002-SPE2DB25FKYB8
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The contract has a ceiling value of $1,949.13 and an ultimate completion date of February 2, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,977.92, is for the supply of Trokendi XR 100 mg capsules, a medication used to treat certain types of seizures. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The award, valued at $5,966.46, has a firm fixed price and an ultimate completion date of May 1, 2024. The contract is not designated with a set-aside. AmerisourceBergen maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,851.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 20, 2024. The contract is not designated with a set-aside requirement, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,148.36 firm fixed-price contract is for the delivery of Trokendi XR 200 mg capsules. The award is not designated as a set-aside contract. The contract is issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,731.13 for the supply of Trokendi XR 100 mg capsules. The contract has an ultimate completion date of January 3, 2025 and a Firm Fixed Price pricing type. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order (SPE2DB22FE9Q9) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The contract is a firm fixed-price agreement with a ceiling value of $2,603.30 and an ultimate completion date of December 8, 2021. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Trokendi XR 200 mg capsules. The contract has a ceiling value of $4,059 and is a firm fixed-price delivery order. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products to federal agencies, including the military and other healthcare providers. This contract does not have a set-aside designation. The award is...
The U.S. government awarded a $3,362.75 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of the specialty drug Trokendi XR 200 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is for a delivery order with the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,354.21, is for the delivery of Trokendi XR 25 mg capsules. The contract is a firm-fixed price delivery order with a completion date of July 25, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...